G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 113 filers reported holding G1 THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.83 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $149,000 | -30.7% | 19,671 | -6.6% | 0.00% | 0.0% |
Q4 2021 | $215,000 | -25.3% | 21,056 | -1.9% | 0.00% | -50.0% |
Q3 2021 | $288,000 | -40.2% | 21,458 | -2.3% | 0.00% | 0.0% |
Q2 2021 | $482,000 | +0.8% | 21,968 | +10.5% | 0.00% | 0.0% |
Q1 2021 | $478,000 | +33.9% | 19,881 | +0.3% | 0.00% | +100.0% |
Q4 2020 | $357,000 | +51.3% | 19,829 | -2.8% | 0.00% | 0.0% |
Q3 2020 | $236,000 | -53.4% | 20,398 | -2.2% | 0.00% | -50.0% |
Q2 2020 | $506,000 | +129.0% | 20,862 | +4.2% | 0.00% | +100.0% |
Q1 2020 | $221,000 | -60.5% | 20,029 | -5.5% | 0.00% | -50.0% |
Q4 2019 | $560,000 | +15.0% | 21,186 | -0.8% | 0.00% | 0.0% |
Q3 2019 | $487,000 | -26.2% | 21,365 | -0.7% | 0.00% | -33.3% |
Q2 2019 | $660,000 | +168.3% | 21,515 | +45.4% | 0.00% | +200.0% |
Q1 2019 | $246,000 | -14.3% | 14,794 | -1.4% | 0.00% | 0.0% |
Q4 2018 | $287,000 | -60.3% | 15,004 | +8.5% | 0.00% | -50.0% |
Q3 2018 | $723,000 | +25.1% | 13,827 | +4.0% | 0.00% | 0.0% |
Q2 2018 | $578,000 | +80.6% | 13,292 | +53.9% | 0.00% | +100.0% |
Q1 2018 | $320,000 | +204.8% | 8,637 | +63.1% | 0.00% | – |
Q4 2017 | $105,000 | -19.2% | 5,296 | +1.6% | 0.00% | – |
Q3 2017 | $130,000 | – | 5,214 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM BioImpact LLC | 1,423,794 | $34,541,000 | 9.18% |
Burrage Capital Management LLC | 373,876 | $9,070,000 | 6.35% |
Birchview Capital, LP | 40,000 | $970,000 | 0.59% |
361 CAPITAL LLC | 47,325 | $1,148,000 | 0.54% |
Rhenman & Partners Asset Management AB | 190,000 | $4,609,000 | 0.50% |
CHI Advisors LLC | 44,000 | $1,067,000 | 0.42% |
Bellevue Group AG | 721,925 | $17,514,000 | 0.25% |
Candriam S.C.A. | 870,423 | $21,117,000 | 0.22% |
Virtus ETF Advisers LLC | 18,991 | $461,000 | 0.22% |
HHLR ADVISORS, LTD. | 949,431 | $23,033,000 | 0.21% |